The Florida Myeloma Community has invited Dr. Rachid Baz, myeloma specialist and leader at Moffitt Cancer Center to speak on the different classes of myeloma drugs and how they are combined for effective treatment against the myeloma. A Q&A session will follow the presentation, so come prepared! We look forward to learning with you.
Audrey introduces the agenda of the event and featured speaker Dr. Rachid Baz.
Dr. Rachid Baz shares on the different classes of myeloma drugs and how they are combined for effective treatment against the myeloma
Audrey joined the HealthTree Foundation as the Myeloma Community Program Director in 2020. While not knowing much about myeloma at the start, she has since worked hard to educate herself, empathize and learn from others' experiences. She loves this job. Audrey is passionate about serving others, loves learning, and enjoys a nice mug of hot chocolate no matter the weather.
Dr. Rachid Baz is a board-certified hematologist and medical oncologist who came to Moffitt in 2008 from Cleveland Clinic. Currently, Dr. Baz is Myeloma Section Head in the Department of Malignant Hematology at Moffitt Cancer Center. In addition, he is the Director of Clinical Research in the Malignant Hematology Department. Dr. Baz is also a Director of the Myeloma Research Center. He has developed a special expertise in managing patients with plasma cell disorders such as multiple myeloma, monoclonal gammopathy of undetermined significance (MGUS), plasmacytoma, primary systematic amyloidosis, and Waldenstrom’s macroglobulinemia (WM). Among other awards, he was the recipient of the Junior Clinical Science Award at Moffitt, and the University of South Florida Outstanding Resident Teaching Award.
Thank you for your interest in the event. If you have any questions, we would love to help!
Feel free to give us a call or send us a message below.
+1 800 709 1113
Support@healthtree.org
Subscribe to the weekly "HealthTree Community for Myeloma Newsletter" for Myeloma news, life with Myeloma stories, Myeloma clinical trials, Myeloma 101 articles and events with Myeloma experts.